Medtronic, Inc. (NYSE:MDT), announced plans for the release of new clinical data on the Endeavor® Zotarolimus-Eluting Coronary Stent System and the Export® Aspiration Catheter at EuroPCR in Barcelona this week, May 13-16. "New data from the ENDEAVOR clinical program and the TAPAS trial have the potential to be practice-changing for interventional cardiology," said Prof.
More...